ciprofloxacin has been researched along with sulfadiazine in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (12.50) | 18.2507 |
| 2000's | 7 (21.88) | 29.6817 |
| 2010's | 16 (50.00) | 24.3611 |
| 2020's | 5 (15.63) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Caugant, DA; Fredlund, H; Hedberg, ST; Nicolas, P; Olcén, P; Unemo, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Avdeef, A; Sun, N; Tam, KY; Tsinman, O | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Alamry, KA; Birs, AS; Gonzalez, CF; Ibrahim, MA; Katritzky, AR; Panda, SS; Serrano, JC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aulicino, TM; Berkowitz, LB; duBouchet, L; Gombert, ME | 1 |
| Hamilton, VE; Reid, RG; Richards, RM; Xing, DK | 1 |
| Richards, RM; Xing, DK | 1 |
| Hellström, P; Kontturi, M; Leppilahti, M; Lukkarinen, O; Tammela, T | 1 |
| Arreaza, L; de la Fuente, L; Fernández, S; Vázquez, JA | 1 |
| Honkanen-Buzalski, T; Lehtolainen, T; Pyörälä, S; Shpigel, NY; Shwimmer, A | 1 |
| Lamshöft, M; Spiteller, M; Sukul, P; Zühlke, S | 1 |
| Clemens, J; Dong, R; Guo, J; Ostermann, A; Siemens, J | 1 |
| Selvam, A; Wong, JW; Zhao, Z | 1 |
| Selvam, A; Wong, JW; Xu, D; Zhao, Z | 1 |
| Jiang, S; Li, Q; Shi, H; Wang, XC | 1 |
| Abbas, Q; Albericio, F; Channar, PA; Hassan, M; Larik, FA; Raza, H; Saeed, A; Seo, SY | 1 |
| Hu, C; Shen, Y; Wang, H; Xing, X; Zhao, D | 1 |
| Hu, C; Shen, Y; Shi, B; Wang, H; Xing, X; Zhao, D | 1 |
| Li, H; Lu, Y; Lu, YX; Song, HL; Xu, H; Yang, XL; Yang, YL; Zhang, S | 1 |
| Chen, C; Ho, SH; Ren, N; Su, G; Xie, P; Zhang, C | 1 |
| Septian, A; Shin, WS | 1 |
| Blasco, J; Colás-Ruiz, NR; Fernandez, R; Hampel, M; Lara-Martín, PA; Mancera, JM; Martínez-Rodríguez, G; Trombini, C | 1 |
| Li, H; Ma, Y; Song, HL; Wang, K; Wu, H; Xu, J; Zou, R | 1 |
1 review(s) available for ciprofloxacin and sulfadiazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for ciprofloxacin and sulfadiazine
| Article | Year |
|---|---|
Prospective randomized open study between ciprofloxacin and a combination of sulfadiazine and trimethoprim in antibiotic prophylaxis in connection with transurethral prostatectomy.
Topics: Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Combinations; Humans; Male; Premedication; Prospective Studies; Prostatectomy; Random Allocation; Sulfadiazine; Trimethoprim; Urinary Tract Infections | 1996 |
30 other study(ies) available for ciprofloxacin and sulfadiazine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
Topics: Africa; Genotype; Humans; Meningitis, Meningococcal; Microbial Sensitivity Tests; Neisseria meningitidis; Phenotype; Sequence Analysis, DNA; Time Factors | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
Topics: Caco-2 Cells; Cell Membrane Permeability; Humans; Hydrogen-Ion Concentration; Membranes, Artificial; Molecular Structure; Pharmaceutical Preparations | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis and antibacterial evaluation of amino acid-antibiotic conjugates.
Topics: Amino Acids; Anti-Bacterial Agents; Bacillus subtilis; Dose-Response Relationship, Drug; Escherichia coli; Metronidazole; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus; Structure-Activity Relationship; Sulfadiazine | 2014 |
Therapy of pulmonary nocardiosis in immunocompromised mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Cortisone; Female; Humans; Imipenem; Immunity, Cellular; Immunologic Deficiency Syndromes; Lung Diseases; Mice; Nocardia asteroides; Nocardia Infections; Sulfadiazine | 1990 |
Study of the mutual effects of sulphadiazine and ciprofloxacin on their uptakes by Pseudomonas aeruginosa.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Pseudomonas aeruginosa; Sulfadiazine | 1994 |
Investigation of synergism between combinations of ciprofloxacin, polymyxin, sulphadiazine and p-aminobenzoic acid.
Topics: 4-Aminobenzoic Acid; Bacteria; Ciprofloxacin; Drug Combinations; Drug Synergism; Microbial Sensitivity Tests; Polymyxins; Pseudomonas aeruginosa; Staphylococcus aureus; Sulfadiazine | 1993 |
[Susceptibility to antimicrobial drugs used in the prophylaxis of meningococcal disease: situation after an epidemic wave].
Topics: Adolescent; Adult; Bacterial Vaccines; Carrier State; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Microbial; Humans; Incidence; Infant; Meningococcal Infections; Meningococcal Vaccines; Microbial Sensitivity Tests; National Health Programs; Neisseria meningitidis; Rifampin; Spain; Sulfadiazine; Time Factors; Vaccination | 2000 |
In vitro antimicrobial susceptibility of Escherichia coli isolates from clinical bovine mastitis in Finland and Israel.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Ceftazidime; Cephalexin; Ciprofloxacin; Dihydrostreptomycin Sulfate; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; Female; Finland; Gentamicins; Israel; Mastitis, Bovine; Microbial Sensitivity Tests; Sulfadiazine; Tetracycline; Trimethoprim | 2003 |
Behaviour of (14)C-sulfadiazine and (14)C-difloxacin during manure storage.
Topics: Anti-Bacterial Agents; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Ciprofloxacin; Manure; Sulfadiazine; Tandem Mass Spectrometry | 2010 |
Short term effects of copper, sulfadiazine and difloxacin on the anaerobic digestion of pig manure at low organic loading rates.
Topics: Anaerobiosis; Animals; Anti-Bacterial Agents; Biofuels; Biotransformation; Ciprofloxacin; Copper Sulfate; Manure; Methanol; Sulfadiazine; Swine | 2012 |
Composting of swine manure spiked with sulfadiazine, chlortetracycline and ciprofloxacin.
Topics: Animals; Anti-Bacterial Agents; Biodegradation, Environmental; Carbon; Carbon Dioxide; Chlortetracycline; Ciprofloxacin; Manure; Nitrogen; Soil; Sulfadiazine; Sus scrofa; Temperature | 2012 |
Fate of tetracycline, sulfonamide and fluoroquinolone resistance genes and the changes in bacterial diversity during composting of swine manure.
Topics: Animals; Anti-Bacterial Agents; Biodegradation, Environmental; Biodiversity; Ciprofloxacin; Denaturing Gradient Gel Electrophoresis; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Manure; Reverse Transcriptase Polymerase Chain Reaction; RNA, Ribosomal, 16S; Soil; Soil Microbiology; Sulfadiazine; Sulfonamides; Swine; Tetracycline | 2012 |
Degradation of typical antibiotics during human feces aerobic composting under different temperatures.
Topics: Aerobiosis; Anti-Bacterial Agents; Chlortetracycline; Ciprofloxacin; Feces; Humans; Manure; Soil; Sulfadiazine; Temperature; Tetracycline; Waste Management; Wood | 2016 |
Sulfonamide-Linked Ciprofloxacin, Sulfadiazine and Amantadine Derivatives as a Novel Class of Inhibitors of Jack Bean Urease; Synthesis, Kinetic Mechanism and Molecular Docking.
Topics: Amantadine; Ciprofloxacin; Enzyme Inhibitors; Fabaceae; Free Radical Scavengers; Inhibitory Concentration 50; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship; Sulfadiazine; Sulfonamides; Urease | 2017 |
Sulfadiazine/ciprofloxacin promote opportunistic pathogens occurrence in bulk water of drinking water distribution systems.
Topics: Amoeba; Anti-Bacterial Agents; Bacteria; Biopolymers; Chlorine; Ciprofloxacin; Disinfectants; Drinking Water; Drug Resistance, Bacterial; Sulfadiazine; Water Microbiology; Water Pollutants; Water Supply | 2018 |
Response of microorganisms in biofilm to sulfadiazine and ciprofloxacin in drinking water distribution systems.
Topics: Anti-Bacterial Agents; Bacteria; Biofilms; Ciprofloxacin; Drinking Water; Environmental Monitoring; Sulfadiazine; Water Pollutants, Chemical | 2019 |
Effect of the coexposure of sulfadiazine, ciprofloxacin and zinc on the fate of antibiotic resistance genes, bacterial communities and functions in three-dimensional biofilm-electrode reactors.
Topics: Anti-Bacterial Agents; Bacteria; Biofilms; Ciprofloxacin; Drug Resistance, Microbial; Electrodes; Genes, Bacterial; Residence Characteristics; Sulfadiazine; Wastewater; Zinc | 2020 |
Revealing the role of adsorption in ciprofloxacin and sulfadiazine elimination routes in microalgae.
Topics: Adsorption; Biodegradation, Environmental; Ciprofloxacin; Microalgae; Sulfadiazine; Water Pollutants, Chemical | 2020 |
Removal of sulfadiazine and ciprofloxacin by clays and manganese oxides: Coupled sorption-oxidation kinetic model.
Topics: Adsorption; Anti-Bacterial Agents; Bentonite; Ciprofloxacin; Clay; Environmental Restoration and Remediation; Kaolin; Kinetics; Manganese; Manganese Compounds; Models, Chemical; Oxidation-Reduction; Oxides; Sulfadiazine | 2020 |
The antibacterials ciprofloxacin, trimethoprim and sulfadiazine modulate gene expression, biomarkers and metabolites associated with stress and growth in gilthead sea bream (Sparus aurata).
Topics: Animals; Anti-Bacterial Agents; Biomarkers; Ciprofloxacin; Ecosystem; Gene Expression; Glutathione Reductase; Perciformes; Sea Bream; Stress, Physiological; Sulfadiazine; Trimethoprim; Water Pollutants, Chemical | 2022 |
Enhanced removal of antibiotic and antibiotic resistance genes by coupling biofilm electrode reactor and manganese ore substrate up-flow microbial fuel cell constructed wetland system.
Topics: Anti-Bacterial Agents; Bacteria; Bioelectric Energy Sources; Biofilms; Ciprofloxacin; Drug Resistance, Microbial; Electrodes; Manganese; Sulfadiazine; Wetlands | 2023 |